{"altmetric_id":2855228,"counts":{"readers":{"mendeley":18,"citeulike":0,"connotea":0},"total":{"posts_count":6},"twitter":{"unique_users_count":6,"unique_users":["EmmaPettengale","MatthiasPiesche","NextGEN_Ltd","christineperal1","3NT","DrMiguelPerales"],"posts_count":6}},"citation":{"abstract":"Antibody agonists targeting tumor necrosis factor (TNF) superfamily receptors, including CD40, are being tested therapeutically as anticancer agents. Studies in mice have shown that anti-CD40 monoclonal antibody (mAb) requires Fc-receptor (FcR) engagement to activate antitumor immunity. In contrast, we have reported that clinically active anti-human CD40 mAb CP-870,893 does not require FcR crosslinking, a finding with translational implications.","abstract_source":"pubmed","altmetric_jid":"536246132a83ee225b8b4590","authors":["Richman LP","Vonderheide RH"],"doi":"10.4161\/onci.28610","first_seen_on":"2014-11-06T11:54:36+00:00","issns":["2162-4011"],"issue":"","journal":"Transactions of the Institute of Measurement and Control, with Measurement + Control","last_mentioned_on":1415271065,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25097801?dopt=Citation"],"pmid":"25097801","pubdate":"2014-08-08T00:00:00+00:00","title":"Anti-human CD40 monoclonal antibody therapy is potent without FcR crosslinking.","type":"article","volume":"3","mendeley_url":"http:\/\/www.mendeley.com\/research\/antihuman-cd40-monoclonal-antibody-therapy-potent-without-fcr-crosslinking"},"altmetric_score":{"score":2.6,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":2.6},"context_for_score":{"all":{"total_number_of_other_articles":4750044,"mean":5.7069650864242,"rank":1808056,"this_scored_higher_than_pct":61,"this_scored_higher_than":2926212,"rank_type":"exact","sample_size":4750044,"percentile":61},"similar_age_3m":{"total_number_of_other_articles":133652,"mean":8.8862283559422,"rank":43506,"this_scored_higher_than_pct":66,"this_scored_higher_than":89513,"rank_type":"exact","sample_size":133652,"percentile":66},"this_journal":{"total_number_of_other_articles":395,"mean":1.792,"rank":58,"this_scored_higher_than_pct":85,"this_scored_higher_than":337,"rank_type":"exact","sample_size":395,"percentile":85},"similar_age_this_journal_3m":{"total_number_of_other_articles":45,"mean":1.6579545454545,"rank":10,"this_scored_higher_than_pct":77,"this_scored_higher_than":35,"rank_type":"exact","sample_size":45,"percentile":77}}},"demographics":{"poster_types":{"member_of_the_public":5,"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1,"Members of the public":5}},"mendeley":{"by_status":{"Researcher":6,"Student  > Ph. D. Student":5,"Student  > Postgraduate":1,"Student  > Master":2,"Other":3,"Professor":1},"by_discipline":{"Medicine and Dentistry":4,"Immunology and Microbiology":2,"Agricultural and Biological Sciences":10,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":1}}},"geo":{"twitter":{"GB":1,"CL":1,"US":1},"mendeley":{"BE":1,"US":1,"CH":1}}},"posts":{"twitter":[{"url":"https:\/\/twitter.com\/EmmaPettengale\/status\/530276881682399232","license":"datasift","rt":["DrMiguelPerales"],"citation_ids":[2855228],"posted_on":"2014-11-06T08:33:55+00:00","author":{"name":"Emma Pettengale","image":"https:\/\/pbs.twimg.com\/profile_images\/460690851719413760\/Vh_lCPWE_normal.jpeg","description":"Commissioning Editor for @PPPublishing All views expressed are my own, RT\u2260Endorsement","id_on_source":"EmmaPettengale","tweeter_id":"390046155","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":837},"tweet_id":"530276881682399232"},{"url":"https:\/\/twitter.com\/MatthiasPiesche\/status\/530311400217145344","license":"datasift","citation_ids":[2855228],"posted_on":"2014-11-06T10:51:05+00:00","author":{"name":"Matthias Piesche","url":"http:\/\/Gofundme.com\/immunotherapy","image":"https:\/\/pbs.twimg.com\/profile_images\/585519282508980225\/zir5JDT6_normal.jpg","description":"AssProf @ UCM. @DanaFarber\/@HarvardMed Alumnus. Interested in #cancer immunology & new biotechnologies. #Fundraising for cancer #immunotherapy research","id_on_source":"MatthiasPiesche","tweeter_id":"1852946341","geo":{"lt":-35.4264,"ln":-71.65542,"country":"CL"},"followers":1751},"tweet_id":"530311400217145344"},{"url":"https:\/\/twitter.com\/NextGEN_Ltd\/status\/530235499592826880","license":"datasift","rt":["DrMiguelPerales"],"citation_ids":[2855228],"posted_on":"2014-11-06T05:49:29+00:00","author":{"name":"\u0412\u043b\u0430\u0434","image":"https:\/\/pbs.twimg.com\/profile_images\/2342353963\/irjhyyc7ed67fugjx2fk_normal.jpeg","id_on_source":"NextGEN_Ltd","tweeter_id":"443359139","geo":{"lt":null,"ln":null},"followers":87},"tweet_id":"530235499592826880"},{"url":"https:\/\/twitter.com\/christineperal1\/status\/530147596828803073","license":"datasift","rt":["DrMiguelPerales"],"citation_ids":[2855228],"posted_on":"2014-11-06T00:00:11+00:00","author":{"name":"Dr Perales@microsoft","image":"http:\/\/pbs.twimg.com\/profile_images\/493875738991276032\/nFU2GFKN_normal.jpeg","id_on_source":"christineperal1","tweeter_id":"2688430574","followers":144},"tweet_id":"530147596828803073"},{"url":"https:\/\/twitter.com\/3NT\/status\/530146785675579392","license":"datasift","rt":["DrMiguelPerales"],"citation_ids":[2855228],"posted_on":"2014-11-05T23:56:58+00:00","author":{"name":"Pieter Droppert","url":"http:\/\/biotechstrategyblog.com","image":"https:\/\/pbs.twimg.com\/profile_images\/903010154731458560\/9e7JONNJ_normal.jpg","description":"I produce @TargetsPodcast & write on @BiotechStrategy about cancer research","id_on_source":"3NT","tweeter_id":"228845995","geo":{"lt":null,"ln":null},"followers":1356},"tweet_id":"530146785675579392"},{"url":"https:\/\/twitter.com\/DrMiguelPerales\/status\/530142885702672384","license":"datasift","citation_ids":[2855228],"posted_on":"2014-11-05T23:41:28+00:00","author":{"name":"Miguel Perales M.D.","url":"http:\/\/www.mskcc.org\/cancer-care\/doctor\/miguel-angel-perales","image":"https:\/\/pbs.twimg.com\/profile_images\/420287281832787968\/QqvGIWhX_normal.jpeg","description":"Oncologist @sloan_kettering. Stem cell transplantation Lymphoma Leukemia MDS Myeloma Immunotherapy Vaccines. @BeTheMatch & @ASBMT Board Member. Tweets mine.","id_on_source":"DrMiguelPerales","tweeter_id":"1407780158","geo":{"lt":43.00035,"ln":-75.4999,"country":"US"},"followers":6527},"tweet_id":"530142885702672384"}]}}